Clinical trial

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.

NCT07227233

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-03-31

PhasePHASE2

Study timeline

Study start (actual)2026-03-31Date precision: day

Registry last updated2026-04-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

A CDK4/6 inhibitor different from the first that the participant had received, plus fulvestrant.DRUG

Treatment of physician's choiceDRUG

Sponsors & collaborators

University of California, San Diegolead sponsor

Mapped research locations

La JollaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07227233 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.